• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Would it be possible to have better ways and routes of administration for vaccines against COVID-19?

作者信息

Atallah Álvaro Nagib, Arbache Samir

机构信息

MD, PhD. Full Professor and Head of the Discipline of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo (SP); and Director of Cochrane Brazil, São Paulo (SP), Brazil.

MD. Preceptor of Dermatology, Universidade de Mogi das Cruzes (UMC), São Paulo (SP), Brazil; and Doctoral Student, Postgraduate Program on Evidence-Based Healthcare, Department of Medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo (SP), Brazil.

出版信息

Sao Paulo Med J. 2021 Jul-Aug;139(4):416-417. doi: 10.1590/1516-3180.2021.0316.18052021.

DOI:10.1590/1516-3180.2021.0316.18052021
PMID:34346963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9615589/
Abstract
摘要

相似文献

1
Would it be possible to have better ways and routes of administration for vaccines against COVID-19?是否有可能找到针对新冠病毒疫苗的更好的给药方式和途径？
Sao Paulo Med J. 2021 Jul-Aug;139(4):416-417. doi: 10.1590/1516-3180.2021.0316.18052021.
2
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
3
Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19.接种针对新型冠状病毒肺炎的mRNA疫苗后的迟发性皮肤反应。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3811-3813. doi: 10.1016/j.jaip.2021.07.012. Epub 2021 Jul 19.
4
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
5
Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection.作者回应：新冠病毒疫苗对严重急性呼吸综合征冠状病毒2感染的有效性和效果：关于无症状严重急性呼吸综合征冠状病毒2感染的更多数据
Euro Surveill. 2021 Sep;26(35). doi: 10.2807/1560-7917.ES.2021.26.35.2100832.
6
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint.通过临床终点预测疫苗诱导的中和抗体的长期动力学和针对 SARS-CoV-2 Delta 变异株的时变疫苗特异性疗效。
BMC Med. 2022 Jan 28;20(1):36. doi: 10.1186/s12916-022-02249-9.
7
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.2021 年 1 月至 4 月，西班牙纳瓦拉地区 COVID-19 疫苗预防 SARS-CoV-2 感染和住院的有效性。
Euro Surveill. 2021 May;26(21). doi: 10.2807/1560-7917.ES.2021.26.21.2100438.
8
COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia.COVID-19 疫苗对德尔塔变异株流行期间有症状的 SARS-CoV-2 的有效性：来自俄罗斯圣彼得堡病例对照研究的初步评估。
BMC Public Health. 2022 Sep 22;22(1):1803. doi: 10.1186/s12889-022-14202-9.
9
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
10
Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.绘制 SARS、MERS 和 SARS-CoV-2 疫苗的技术图谱。
Drug Dev Ind Pharm. 2021 Apr;47(4):673-684. doi: 10.1080/03639045.2021.1908343. Epub 2021 Apr 7.

本文引用的文献

1
Treatment of idiopathic guttate hypomelanosis with a tattoo device versus a handheld needle.使用纹身设备与手持针头治疗特发性点滴状色素减退症。
JAAD Int. 2021 Mar 6;3:14-16. doi: 10.1016/j.jdin.2021.01.005. eCollection 2021 Jun.
2
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects.真皮层接种疫苗：技术、挑战与前景
Vaccines (Basel). 2020 Sep 16;8(3):534. doi: 10.3390/vaccines8030534.
3
How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?新型给药技术采用纹身机给药，其输送的药物剂量是多少？
Int J Dermatol. 2019 Jun;58(6):750-755. doi: 10.1111/ijd.14408. Epub 2019 Mar 3.
4
Microneedle-based vaccines.基于微针的疫苗。
Curr Top Microbiol Immunol. 2009;333:369-93. doi: 10.1007/978-3-540-92165-3_18.
5
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.一种通过体内监测抗原表达来定义的快速且有效的DNA疫苗接种策略。
Nat Med. 2005 Aug;11(8):899-904. doi: 10.1038/nm1264. Epub 2005 Jun 19.
6
Innate immunity.固有免疫
N Engl J Med. 2000 Aug 3;343(5):338-44. doi: 10.1056/NEJM200008033430506.
7
[Tattoo pigment in regional lymph nodes--an identifying marker?].[区域淋巴结中的纹身色素——一种识别标记？]
Arch Kriminol. 1992 Nov-Dec;190(5-6):163-70.